Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Side-effects news

Show

From To
Is lipodystrophy caused by the action of antiretroviral drugs in the brain?

Lipodystrophy could be caused by the effects of antiretroviral drugs on specific brain regions, according to a hypothesis presented by Dutch researchers in the November

Published
04 December 2003
By
Christopher Gadd
HAART may cause oxidant stress says US study

An American study to be published in the December 15th edition of Clinical Infectious Diseases (now available on-line) found that HIV-positive individuals treated with HAART

Published
03 December 2003
By
Michael Carter
HAART patients at greater risk of severe side-effects than AIDS

HIV-positive individuals who take HAART are more likely to experience a serious or life-threatening treatment side-effect than develop an AIDS-defining condition, according to a US

Published
02 December 2003
By
Michael Carter
Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment

Over 50% of patients taking anti-HIV treatments for the first time will change or stop taking their drugs in the first year of therapy, often

Published
27 November 2003
By
Michael Carter
Talking about side-effects

Monitoring and communication about antiretroviral side-effects in low-resource settings.

Published
08 May 2003
From
HIV & AIDS treatment in practice
Lipodystrophy seen in primary infection HAART patients

Body fat alterations (lipodystrophy) are being seen just one year after individuals with primary HIV infection commence HAART, warned an Australian doctor at the Lisbon

Published
05 March 2001
By
Keith Alcorn
← Prev1...8081828384Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.